Buying Nu gives Shilpa access to an oral fast-dissolving thin strip dosage form. Using this and other capabilities at Nu, Shilpa plans to expand beyond its ingredients focus and enter niche formulation markets.
Raichur, India-based Shilpa is primarily focused on production and marketing of active pharmaceutical ingredients (API), fine chemicals and intermediates. Shares in Shilpa spiked following the news but fell back to close near to where they started the day.